Do Cardiovascular Risk Factors Influence Cardiac Allograft Vasculopathy?

Transplantation Proceedings

Volumn 38, Issue 8, 2006, Pages 2572-2574

  Chamorro, C I ^a   Almenar, L ^a   Martinez Dolz L ^a   Sanchez Lacuesta E ^a   Martin Pastor J ^a   Ten Morro, F ^a   Sanchez Soriano R M ^a   Aguero J ^a   Ortiz, V ^a   Moro, J A ^a   Salvador, A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FISHER EXACT TEST; HEART FAILURE; HUMAN; INTRAVASCULAR ULTRASOUND; LIPOPROTEIN BLOOD LEVEL; ORGAN DONOR; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TRIACYLGLYCEROL BLOOD LEVEL; UNIVARIATE ANALYSIS;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; DIABETES MELLITUS; DYSLIPIDEMIAS; HEART TRANSPLANTATION; HUMANS; MIDDLE AGED; RISK FACTORS; SMOKING; TRANSPLANTATION, HOMOLOGOUS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33750608870     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.034     Document Type: Article

References (8)

1. Kobashigawa J. What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?. Curr Control Trials Cardiovasc Med 1 (2000) 166
2. Labarrere C.A. Relationship of fibrin deposition in microvasculature to outcomes in cardiac transplantation. Curr Opin Cardiol 14 (1999) 133
3. Kapadia S.R., Ziada K.M., L'Allier P.L., et al. Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging. J Heart Lung Transplant 19 (2000) 167
4. Tuzcu E.M., Kapadia S.R., Sachar R., et al. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol 45 (2005) 1538
5. Billingham M.E. Histopathology of graft coronary disease. J Heart Lung Transplant 11 (1992) S38
6. Lindenfeld J., Page II R.L., Zolty R., et al. Drug therapy in the heart transplant recipient: Part III: common medical problems. Circulation 111 (2005) 113
7. Rickenbacher P.R., Kemna M.S., Pinto F.J., et al. Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors. Transplantation 61 (1996) 46
8. Eisen H.J., Tuzcu E.M., Dorent R., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349 (2003) 847